{"gene":"PF3D7_0208500","run_date":"2026-09-07T10:55:51","timeline":{"discoveries":[{"year":1998,"finding":"ACP (PF3D7_0208500) is a nuclear-encoded protein that localizes to the apicoplast in P. falciparum, as verified by immunolocalization; the ACP N-terminal presequence is sufficient to target a recombinant GFP reporter to the apicoplast in transgenic T. gondii, implicating ACP and apicoplast fatty acid biosynthesis as an essential function of the organelle.","method":"Immunolocalization of endogenous ACP; GFP reporter targeting assay in transgenic T. gondii","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct immunolocalization in P. falciparum combined with GFP-targeting reporter assay in T. gondii, two orthogonal methods, foundational study replicated by subsequent work","pmids":["9770490"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2002,"finding":"Purified recombinant P. falciparum ACP is activated by addition of a 4'-phosphopantetheine (4'-PP) prosthetic group derived from coenzyme A to generate holo-PfACP; holo-PfACP is an effective substrate for the transacylase activity of PfKASIII in vitro, establishing ACP's role as acyl group carrier in the type II FAS pathway.","method":"Recombinant protein expression, in vitro 4'-PP modification assay, transacylase activity assay with PfKASIII","journal":"Molecular and biochemical parasitology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of ACP activation and substrate activity, single lab but two orthogonal biochemical assays","pmids":["12270624"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2003,"finding":"Pure recombinant pfMCAT catalyzes malonyl transfer from malonyl-CoA to pfACP in vitro, generating malonyl-pfACP; this product is then a substrate for pfKASIII, which catalyzes decarboxylative condensation. Notably, pfACP(trans), a construct containing the N-terminal apicoplast transit peptide, was NOT a substrate for pfMCAT, demonstrating that the transit peptide interferes with enzyme recognition.","method":"In vitro malonyl transfer assay with recombinant pfMCAT and pfACP; kinetic characterization of pfKASIII with malonyl-pfACP","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified recombinant proteins, kinetic parameters determined, negative control with transit-peptide-containing construct tested","pmids":["12549938"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2005,"finding":"P. falciparum ACP (apicoplast form) can functionally replace E. coli AcpP in vivo, restoring growth to an E. coli temperature-sensitive acpP mutant strain, demonstrating that PfACP is functionally interchangeable with bacterial ACP despite evolutionary distance.","method":"In vivo complementation of E. coli acpP temperature-sensitive mutant with recombinant PfACP","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean in vivo genetic complementation assay, single lab, single method","pmids":["17522044"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"finding":"High-resolution NMR solution structures of holo-PfACP reveal two conformational equilibrium states arising from different orientations of the 4'-phosphopantetheine (4'-PP) prosthetic group; the 4'-PP interacts with the polypeptide backbone, and a conformational switch between the two states is proposed to be essential for ACP activation. The structures consist of three tightly packed helices stabilized by hydrophobic interactions.","method":"High-resolution NMR structure determination (20 structures each form, >1200 NOEs including 4'-PP-protein NOEs, backbone dihedral angles, hydrogen bonds)","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with functional validation of prosthetic group-protein interactions, multiple orthogonal NMR experiments in single rigorous study","pmids":["16734426"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"finding":"Falcilysin (FLN), a zinc metalloprotease found in the P. falciparum apicoplast, cleaves the transit peptide from apicoplast-resident ACP in vitro, supporting a role for FLN in transit peptide degradation after proteolytic release from ACP precursor protein.","method":"In vitro cleavage assay of ACP transit peptide by recombinant falcilysin; GFP-FLN transgenic parasite localization","journal":"Molecular microbiology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vitro cleavage assay is Tier 1 but ACP used only as substrate reagent; single lab, single biochemical assay for ACP-specific finding","pmids":["17074076"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2007,"finding":"PfACP exhibits self-acylation activity intrinsic to the individual protein, selectively using dicarboxylic acids as substrates; mutational analysis identified key residues required for this self-acylation. This demonstrates that self-acylation is not restricted to ACPs in polyketide biosynthesis but extends to type II FAS ACPs.","method":"In vitro self-acylation assay with recombinant PfACP; site-directed mutagenesis of key residues","journal":"Chemistry & biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical assay combined with mutagenesis, single lab, two complementary methods","pmids":["17656314"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"finding":"NMR structural studies on acyl-ACP intermediates of P. falciparum show that the hydrophobic core of ACP can sequester acyl chains up to 12 carbons; additional carbons protrude from the hydrophobic cavity. A unique side chain-to-backbone hydrogen bond between Ile-55 HN and Glu-48 O, combined with charge-charge repulsion between helix II and helix III, provides the molecular mechanism for ACP core expansion to accommodate longer acyl chains.","method":"NMR (chemical shift perturbation, 13C,15N-double-filtered NOESY, pKa measurement) on acyl-ACP intermediates","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR with multiple orthogonal experiments (CSP, dNOESY, pKa), mechanistic conclusions validated by multiple NMR approaches in single rigorous study","pmids":["19520851"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"finding":"Recombinant PfACP from P. falciparum exhibits malonyl transferase activity intrinsic to the individual ACP; mutational analysis identifies an arginine/lysine in loop II and an arginine/glutamine in helix III as catalytic residues essential for the malonyl transferase reaction, and this activity can complement a fabD(Ts) E. coli strain.","method":"In vitro malonyl transferase assay; site-directed mutagenesis; in vivo complementation of fabD(Ts) E. coli","journal":"Molecular bioSystems","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic assay with mutagenesis plus in vivo genetic complementation, two orthogonal methods in single study","pmids":["19462023"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"finding":"The ACP targeting sequence is used to drive GFP to the apicoplast in live P. berghei parasites; live imaging shows the apicoplast remains as a single branched organelle until nuclear division is complete, then rapidly segregates into daughter cells across all three asexual replication phases.","method":"Live fluorescence microscopy of P. berghei expressing GFP fused to ACP targeting sequence; FRAP and time-lapse imaging","journal":"Biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct live-cell localization using ACP targeting sequence as apicoplast marker; ACP sequence used as tool, functional consequence of ACP localization itself not directly tested; single lab","pmids":["19143588"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2010,"finding":"Crystal structures of P. falciparum ACP in both reduced (monomer) and disulfide-linked (dimer) forms reveal the disulfide in the cross-linked dimer is sequestered from bulk solvent at a tight molecular interface. Biochemical analysis of blood-stage parasites shows monomeric (reduced, holo) PfACP predominates; the disulfide-linked form is not detected even under oxidative stress, indicating the apicoplast maintains a reducing environment during blood-stage growth.","method":"X-ray crystallography of reduced and disulfide-linked ACP; solvent accessibility assays with reducing agents; non-reducing SDS-PAGE of parasite lysates; diamide treatment of blood-stage parasites","journal":"Proteins","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure plus multiple orthogonal biochemical experiments on parasite lysates in single rigorous study","pmids":["19768685"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2011,"finding":"NMR analysis of the P. falciparum ACP transit peptide shows it is intrinsically disordered (unstructured) in vitro; in vivo mutagenesis studies demonstrate that increased helical content in the transit peptide disrupts apicoplast import, while transit peptides with proline-enforced disorder support robust apicoplast localization, establishing that structural disorder is a functional requirement for ACP transit peptide-mediated apicoplast targeting.","method":"NMR structural analysis of isolated transit peptide; in vivo apicoplast import assay with proline-substitution and helix-stabilizing mutants in P. falciparum","journal":"Traffic (Copenhagen, Denmark)","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR combined with functional in vivo import assay with multiple mutants, two orthogonal methods in single study","pmids":["21668595"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"finding":"FabI (enoyl-ACP reductase) colocalizes with apicoplast-targeted ACP in P. falciparum oocyst sporozoites, confirming FabI functions in the apicoplast as part of the type II FAS pathway; targeted deletion of fabI and fabB/F abolishes sporozoite development within the midgut oocyst without affecting asexual blood-stage replication.","method":"Immunofluorescence colocalization of FabI with ACP; targeted gene deletion and phenotypic analysis across life cycle stages","journal":"Eukaryotic cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — colocalization used ACP as apicoplast marker; ACP itself not manipulated; finding is about FabI but validates ACP as apicoplast marker and FAS component","pmids":["24297444"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2021,"finding":"ACP knockdown leads to loss of ACP immunofluorescence signal and loss of the apicoplast genome in P. falciparum PfΔGyrA parasites, indicating ACP is an established marker for apicoplast integrity used to confirm organelle loss.","method":"CRISPR/Cas9 gene editing of PfGyrA; ACP immunofluorescence as readout for apicoplast presence","journal":"Antimicrobial agents and chemotherapy","confidence":"Low","confidence_rationale":"Tier 3 / Weak — ACP used only as immunofluorescence marker for apicoplast; no direct mechanistic study of ACP function","pmids":["34152814"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2005,"finding":"A P. falciparum ACPS-type phosphopantetheinyl transferase (PfACPS-PPT) is responsible for synthesizing holo-ACP from apo-ACP; PfACPS-PPT is bifunctional (fused to a metal-dependent hydrolase domain), is predicted to be targeted to the apicoplast, and is more closely related to proteobacterial PPTases than to animal or SFP-type PPTases.","method":"Bioinformatic identification; functional characterization of homologous CpSFP-PPT by in vitro and in vivo assays in E. coli (PfACPS-PPT not directly assayed in vitro)","journal":"Eukaryotic cell","confidence":"Low","confidence_rationale":"Tier 4 / Weak — PfACPS-PPT identified bioinformatically; direct biochemical characterization performed only for C. parvum homolog, not PfACPS-PPT itself","pmids":["16002647"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2026,"finding":"Knockout or ligand-dependent knockdown of apicoplast ACP (PF3D7_0208500) is lethal to blood-stage P. falciparum independently of type II fatty acid synthesis activity; loss of ACP impairs biosynthesis of essential isoprenoid precursors and blocks apicoplast biogenesis. Proximity biotinylation and biochemical interaction studies show ACP binds and stabilizes apicoplast pyruvate kinase II (PKII), the only known source of NTPs in the apicoplast; ACP knockdown causes loss of PKII, which is sufficient to explain ACP essentiality at this stage.","method":"CRISPR/Cas9 knockout; ligand-dependent knockdown (conditional expression); proximity biotinylation (BioID); co-immunoprecipitation/biochemical interaction studies; isoprenoid biosynthesis assay; apicoplast biogenesis imaging","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (genetic KO, conditional KD, proximity biotinylation, biochemical interaction, functional rescue assays) establishing a specific essential non-FAS mechanism","pmids":["41959251"],"is_preprint":true,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"P. falciparum apicoplast ACP (PF3D7_0208500) is a nuclear-encoded protein bearing an N-terminal bipartite targeting sequence (signal peptide + intrinsically disordered transit peptide) that directs it to the apicoplast, where it is maintained in a reduced, holo (4'-phosphopantetheine-modified) state; it functions as the canonical acyl-chain scaffold and carrier for apicoplast type II fatty acid synthesis (accepting malonyl groups from MCAT, donating acyl intermediates to KASIII and other FAS enzymes, and expanding its hydrophobic core to accommodate growing acyl chains), and additionally exhibits intrinsic self-acylation and malonyl transferase activities; beyond FAS, ACP plays an essential FASII-independent role in blood-stage parasites by binding and stabilizing apicoplast pyruvate kinase II (PKII)—the sole NTP source in the organelle—thereby supporting isoprenoid precursor biosynthesis and apicoplast biogenesis, such that ACP loss is lethal in blood stages even when FAS is dispensable."},"narrative":{"mechanistic_narrative":"PF3D7_0208500 (ACP) is a nuclear-encoded apicoplast acyl carrier protein of P. falciparum that serves as the central acyl-chain scaffold of the organellar type II fatty acid synthesis (FASII) pathway [PMID:9770490, PMID:12270624]. It is imported into the apicoplast via an N-terminal bipartite presequence sufficient to target reporters to the organelle, whose transit peptide must remain intrinsically disordered for productive import and is proteolytically removed inside the apicoplast [PMID:9770490, PMID:21668595, PMID:17074076]. ACP is activated to its holo form by addition of a 4'-phosphopantetheine prosthetic group derived from coenzyme A [PMID:12270624], and its NMR/crystal structures reveal a three-helix fold whose hydrophobic core sequesters acyl chains up to twelve carbons and expands via defined helix II/III interactions to accommodate longer chains, with a conformational switch of the prosthetic group linked to activation [PMID:16734426, PMID:19520851]. In blood-stage parasites ACP is maintained predominantly in a reduced, monomeric holo state, reflecting a reducing apicoplast environment [PMID:19768685]. Mechanistically, ACP accepts malonyl groups from MCAT to form malonyl-ACP and donates acyl intermediates to KASIII for decarboxylative condensation [PMID:12270624, PMID:12549938], and it additionally displays intrinsic self-acylation and malonyl transferase activities dependent on identified catalytic residues [PMID:17656314, PMID:19462023]; its functional interchangeability with bacterial ACP underscores the conservation of these roles [PMID:17522044, PMID:19462023]. Beyond FASII, ACP is essential in blood stages independently of fatty acid synthesis: it binds and stabilizes apicoplast pyruvate kinase II (PKII), and ACP loss depletes PKII, impairs isoprenoid precursor biosynthesis, and blocks apicoplast biogenesis, rendering ACP knockdown lethal [PMID:41959251].","teleology":[{"year":1998,"claim":"Established where ACP acts and implicated apicoplast fatty acid biosynthesis as an essential organellar function, framing all subsequent mechanistic work.","evidence":"Immunolocalization of endogenous ACP in P. falciparum plus GFP presequence-targeting reporter in transgenic T. gondii","pmids":["9770490"],"confidence":"High","gaps":["Did not test whether FASII/ACP is essential in blood stages","No biochemical activity demonstrated"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2002,"claim":"Demonstrated that ACP requires 4'-phosphopantetheine activation to function as the acyl carrier that feeds KASIII, defining its core biochemical role in FASII.","evidence":"Recombinant expression, in vitro 4'-PP modification, and transacylase assay with PfKASIII","pmids":["12270624"],"confidence":"High","gaps":["In vitro reconstitution only","Identity of the physiological PPTase not established here"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2003,"claim":"Placed ACP within the FASII enzyme cascade by showing it accepts malonyl from MCAT and that the transit peptide blocks enzyme recognition, indicating processing is required for function.","evidence":"In vitro malonyl transfer with recombinant pfMCAT and pfACP, kinetics with pfKASIII, and negative control with transit-peptide-containing construct","pmids":["12549938"],"confidence":"High","gaps":["Used recombinant proteins outside the organelle","Did not resolve when/where the transit peptide is cleaved in vivo"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2005,"claim":"Tested the depth of functional conservation of ACP, showing the Plasmodium protein can substitute for bacterial ACP in vivo.","evidence":"In vivo complementation of an E. coli acpP temperature-sensitive mutant with PfACP","pmids":["17522044"],"confidence":"Medium","gaps":["Single-method genetic assay","Does not address Plasmodium-specific partner interactions"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2005,"claim":"Proposed the enzyme responsible for generating holo-ACP, addressing how apo-ACP is activated in the apicoplast.","evidence":"Bioinformatic identification of PfACPS-PPT with functional characterization performed on the C. parvum homolog, not PfACPS-PPT itself","pmids":["16002647"],"confidence":"Low","gaps":["PfACPS-PPT never directly assayed on PfACP","Apicoplast targeting only predicted","No in vivo demonstration of holo-ACP synthesis by this enzyme"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"claim":"Provided the atomic structure of holo-ACP and linked a prosthetic-group conformational switch to activation, explaining how the carrier presents its cargo.","evidence":"High-resolution NMR solution structures of two holo-PfACP conformers with 4'-PP-protein NOEs","pmids":["16734426"],"confidence":"High","gaps":["Functional role of the two states not tested by mutation","No acyl-loaded structure in this study"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2007,"claim":"Revealed an intrinsic self-acylation activity of ACP using dicarboxylic acids, expanding its catalytic repertoire beyond passive carrier function.","evidence":"In vitro self-acylation assay with recombinant PfACP plus site-directed mutagenesis of key residues","pmids":["17656314"],"confidence":"Medium","gaps":["Physiological relevance of self-acylation in vivo unclear","Single in vitro system"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"claim":"Defined the structural basis for accommodating growing acyl chains, explaining how one carrier handles substrates of increasing length during FASII elongation.","evidence":"NMR of acyl-ACP intermediates (CSP, double-filtered NOESY, pKa) identifying core expansion mechanism","pmids":["19520851"],"confidence":"High","gaps":["Behavior with the full complement of FAS enzymes not tested","Upper limit of chain capacity in vivo not established"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"claim":"Showed ACP itself carries intrinsic malonyl transferase activity with identified catalytic residues, further blurring the carrier/enzyme boundary.","evidence":"In vitro malonyl transferase assay, mutagenesis, and in vivo complementation of a fabD(Ts) E. coli strain","pmids":["19462023"],"confidence":"High","gaps":["Contribution of this activity relative to MCAT in vivo unclear","No parasite genetic test of the catalytic residues"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2011,"claim":"Established that intrinsic disorder of the ACP transit peptide is a functional requirement for apicoplast import, defining the biophysical rule governing its targeting.","evidence":"NMR of the isolated transit peptide plus in vivo import assays with proline-disorder and helix-stabilizing mutants in P. falciparum","pmids":["21668595"],"confidence":"High","gaps":["Import receptor recognizing the disordered peptide not identified","Sequence-specific determinants not mapped"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"claim":"Determined that ACP is kept in a reduced monomeric holo state in blood stages, establishing the redox environment of the functional carrier.","evidence":"X-ray crystallography of reduced and disulfide-linked forms plus non-reducing PAGE and diamide treatment of blood-stage parasites","pmids":["19768685"],"confidence":"High","gaps":["Functional role of the disulfide-linked dimer, if any, undefined","Redox state in other life-cycle stages not examined"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"claim":"Used ACP to define the FASII pathway's stage-specific requirement, showing FAS enzymes act in the apicoplast and are needed for mosquito-stage but not blood-stage growth.","evidence":"Immunofluorescence colocalization of FabI with ACP and targeted deletion of fabI and fabB/F across life-cycle stages in P. falciparum","pmids":["24297444"],"confidence":"Medium","gaps":["ACP itself not deleted here","Does not address why ACP is essential in blood stages if FASII is dispensable"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2026,"claim":"Resolved the paradox of blood-stage essentiality by showing ACP acts independently of FASII, stabilizing PKII and supporting isoprenoid precursor synthesis and apicoplast biogenesis.","evidence":"CRISPR knockout, ligand-dependent knockdown, BioID proximity biotinylation, co-IP, isoprenoid and apicoplast biogenesis assays in P. falciparum (preprint)","pmids":["41959251"],"confidence":"High","gaps":["Molecular basis of ACP-PKII binding not structurally defined","Whether ACP stabilizes additional apicoplast proteins not established","Preprint, not yet peer-reviewed"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"How ACP's canonical FASII carrier role is mechanistically coupled to its FASII-independent PKII-stabilizing function within the same molecule remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of the ACP-PKII complex","Unknown whether the acyl-carrier and PKII-binding surfaces overlap","Identity of the endogenous apicoplast PPTase remains bioinformatic"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":["ACP-PKII (apicoplast pyruvate kinase II) complex [#15]"],"partners":["PFKASIII (BETA-KETOACYL-ACP SYNTHASE III) [#1, #2]","PFMCAT (MALONYL-COA:ACP TRANSACYLASE) [#2]","FABI (ENOYL-ACP REDUCTASE) [#12]","FALCILYSIN (FLN, TRANSIT PEPTIDE CLEAVAGE) [#5]","PFACPS-PPT (PREDICTED PHOSPHOPANTETHEINYL TRANSFERASE) [#14]","APICOPLAST PYRUVATE KINASE II (PKII) [#15]"],"other_free_text":["Nuclear-encoded, imported into the apicoplast via an N-terminal bipartite presequence; transit peptide must be intrinsically disordered for import [#0, #11].","Activated to holo form by 4'-phosphopantetheine addition; adopts a three-helix fold whose hydrophobic core expands to accommodate acyl chains up to and beyond 12 carbons [#4, #7].","Maintained predominantly reduced and monomeric in blood-stage parasites, reflecting a reducing apicoplast environment [#10].","Functionally interchangeable with bacterial ACP (E. coli acpP and fabD complementation) [#3, #8].","Essential in blood stages independently of type II fatty acid synthesis; loss blocks isoprenoid precursor biosynthesis and apicoplast biogenesis [#15].","Widely used as an apicoplast marker to monitor organelle integrity [#9, #13]."]}},"prefetch_data":{},"corpus_meta":[{"pmid":"9770490","id":"PMC_9770490","title":"Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9770490","citation_count":600,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":true,"competing_organism_match":"Toxoplasma","competing_organism_only":false},{"pmid":"24297444","id":"PMC_24297444","title":"Type II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoes.","date":"2013","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/24297444","citation_count":120,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12549938","id":"PMC_12549938","title":"The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII.","date":"2003","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12549938","citation_count":75,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17522044","id":"PMC_17522044","title":"In vivo functional analyses of the type II acyl carrier proteins of fatty acid biosynthesis.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17522044","citation_count":66,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19143588","id":"PMC_19143588","title":"GFP-targeting allows visualization of the apicoplast throughout the life cycle of live malaria parasites.","date":"2009","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/19143588","citation_count":65,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16225460","id":"PMC_16225460","title":"Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16225460","citation_count":63,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16198563","id":"PMC_16198563","title":"Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives.","date":"2005","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/16198563","citation_count":63,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16734426","id":"PMC_16734426","title":"Solution structures of conformationally equilibrium forms of holo-acyl carrier protein (PfACP) from Plasmodium falciparum provides insight into the mechanism of activation of ACPs.","date":"2006","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16734426","citation_count":61,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17074076","id":"PMC_17074076","title":"A role for falcilysin in transit peptide degradation in the Plasmodium falciparum apicoplast.","date":"2006","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/17074076","citation_count":61,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15086316","id":"PMC_15086316","title":"Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15086316","citation_count":60,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12906873","id":"PMC_12906873","title":"Apicoplast fatty acid biosynthesis as a target for medical intervention in apicomplexan parasites.","date":"2003","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/12906873","citation_count":59,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19768685","id":"PMC_19768685","title":"Plasmodium falciparum acyl carrier protein crystal structures in disulfide-linked and reduced states and their prevalence during blood stage growth.","date":"2010","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/19768685","citation_count":58,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17567585","id":"PMC_17567585","title":"X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17567585","citation_count":56,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16893651","id":"PMC_16893651","title":"Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli.","date":"2006","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16893651","citation_count":55,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15680992","id":"PMC_15680992","title":"Anti-protozoal and plasmodial FabI enzyme inhibiting metabolites of Scrophularia lepidota roots.","date":"2005","source":"Phytochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15680992","citation_count":54,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15930004","id":"PMC_15930004","title":"The crystal structure of PfFabZ, the unique beta-hydroxyacyl-ACP dehydratase involved in fatty acid biosynthesis of Plasmodium falciparum.","date":"2005","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/15930004","citation_count":54,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12270624","id":"PMC_12270624","title":"Functional characterization of the acyl carrier protein (PfACP) and beta-ketoacyl ACP synthase III (PfKASIII) from Plasmodium falciparum.","date":"2002","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/12270624","citation_count":52,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16466916","id":"PMC_16466916","title":"Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives.","date":"2006","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/16466916","citation_count":47,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17263522","id":"PMC_17263522","title":"Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).","date":"2007","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17263522","citation_count":45,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17327670","id":"PMC_17327670","title":"Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents.","date":"2007","source":"Acta crystallographica. Section D, Biological crystallography","url":"https://pubmed.ncbi.nlm.nih.gov/17327670","citation_count":42,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["acyl carrier protein"],"competing_organism_flag":true,"competing_organism_match":"Toxoplasma","competing_organism_only":false},{"pmid":"15139852","id":"PMC_15139852","title":"Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15139852","citation_count":41,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24231338","id":"PMC_24231338","title":"In vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives.","date":"2013","source":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24231338","citation_count":39,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33493916","id":"PMC_33493916","title":"Natural biflavonoids as potential therapeutic agents against microbial diseases.","date":"2021","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/33493916","citation_count":36,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21668595","id":"PMC_21668595","title":"Plasmodium falciparum apicoplast transit peptides are unstructured in vitro and during apicoplast import.","date":"2011","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/21668595","citation_count":34,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"27353755","id":"PMC_27353755","title":"Overexpression of Plasmodium berghei ATG8 by Liver Forms Leads to Cumulative Defects in Organelle Dynamics and to Generation of Noninfectious Merozoites.","date":"2016","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/27353755","citation_count":32,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"22607141","id":"PMC_22607141","title":"Lipoic acid metabolism of Plasmodium--a suitable drug target.","date":"2012","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/22607141","citation_count":31,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16265894","id":"PMC_16265894","title":"The plastid of Plasmodium spp.: a target for inhibitors.","date":"2005","source":"Current topics in microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16265894","citation_count":27,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17656314","id":"PMC_17656314","title":"Self-acylation properties of type II fatty acid biosynthesis acyl carrier protein.","date":"2007","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/17656314","citation_count":27,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16246025","id":"PMC_16246025","title":"Plasmodium falciparum possesses organelle-specific alpha-keto acid dehydrogenase complexes and lipoylation pathways.","date":"2005","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/16246025","citation_count":25,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19520851","id":"PMC_19520851","title":"Structural insights into the acyl intermediates of the Plasmodium falciparum fatty acid synthesis pathway: the mechanism of expansion of the acyl carrier protein core.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19520851","citation_count":25,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16002647","id":"PMC_16002647","title":"Functional characterization of an evolutionarily distinct phosphopantetheinyl transferase in the apicomplexan Cryptosporidium parvum.","date":"2005","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/16002647","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":true,"competing_organism_match":"Cryptosporidium","competing_organism_only":true},{"pmid":"18424102","id":"PMC_18424102","title":"Inhibiting enoyl-ACP reductase (FabI) across pathogenic microorganisms by linear sesquiterpene lactones from Anthemis auriculata.","date":"2008","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18424102","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16934037","id":"PMC_16934037","title":"Analyses of co-operative transitions in Plasmodium falciparum beta-ketoacyl acyl carrier protein reductase upon co-factor and acyl carrier protein binding.","date":"2006","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/16934037","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16467310","id":"PMC_16467310","title":"Recombinant expression and biochemical characterization of the unique elongating beta-ketoacyl-acyl carrier protein synthase involved in fatty acid biosynthesis of Plasmodium falciparum using natural and artificial substrates.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16467310","citation_count":23,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17485508","id":"PMC_17485508","title":"Mass spectrometry-based systems approach for identification of inhibitors of Plasmodium falciparum fatty acid synthase.","date":"2007","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/17485508","citation_count":21,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"34612205","id":"PMC_34612205","title":"Divergent acyl carrier protein decouples mitochondrial Fe-S cluster biogenesis from fatty acid synthesis in malaria parasites.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34612205","citation_count":18,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15823545","id":"PMC_15823545","title":"A novel approach for over-expression, characterization, and isotopic enrichment of a homogeneous species of acyl carrier protein from Plasmodium falciparum.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15823545","citation_count":17,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19007113","id":"PMC_19007113","title":"Mechanical features of Plasmodium falciparum acyl carrier protein in the delivery of substrates.","date":"2008","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/19007113","citation_count":17,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19462023","id":"PMC_19462023","title":"Catalysis and mechanism of malonyl transferase activity in type II fatty acid biosynthesis acyl carrier proteins.","date":"2009","source":"Molecular bioSystems","url":"https://pubmed.ncbi.nlm.nih.gov/19462023","citation_count":15,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"41959251","id":"PMC_41959251","title":"Acyl Carrier Protein is Essential for Apicoplast Biogenesis in Malaria Parasites Independent of Fatty Acid Synthesis.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41959251","citation_count":1,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"34152814","id":"PMC_34152814","title":"Properties of Plasmodium falciparum with a Deleted Apicoplast DNA Gyrase.","date":"2021","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/34152814","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ACP","acyl carrier protein"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":23273,"output_tokens":4750,"usd":0.070534,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11202,"output_tokens":4893,"usd":0.089167,"stage2_stop_reason":"end_turn"},"total_usd":0.159701,"stage1_batch_id":"msgbatch_01DbiymDmubkPpYvdbAu5a7V","stage2_batch_id":"msgbatch_012TbrWvMRH129T7PQ4SmvrJ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"ACP (PF3D7_0208500) is a nuclear-encoded protein that localizes to the apicoplast in P. falciparum, as verified by immunolocalization; the ACP N-terminal presequence is sufficient to target a recombinant GFP reporter to the apicoplast in transgenic T. gondii, implicating ACP and apicoplast fatty acid biosynthesis as an essential function of the organelle.\",\n      \"method\": \"Immunolocalization of endogenous ACP; GFP reporter targeting assay in transgenic T. gondii\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct immunolocalization in P. falciparum combined with GFP-targeting reporter assay in T. gondii, two orthogonal methods, foundational study replicated by subsequent work\",\n      \"pmids\": [\"9770490\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Purified recombinant P. falciparum ACP is activated by addition of a 4'-phosphopantetheine (4'-PP) prosthetic group derived from coenzyme A to generate holo-PfACP; holo-PfACP is an effective substrate for the transacylase activity of PfKASIII in vitro, establishing ACP's role as acyl group carrier in the type II FAS pathway.\",\n      \"method\": \"Recombinant protein expression, in vitro 4'-PP modification assay, transacylase activity assay with PfKASIII\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of ACP activation and substrate activity, single lab but two orthogonal biochemical assays\",\n      \"pmids\": [\"12270624\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Pure recombinant pfMCAT catalyzes malonyl transfer from malonyl-CoA to pfACP in vitro, generating malonyl-pfACP; this product is then a substrate for pfKASIII, which catalyzes decarboxylative condensation. Notably, pfACP(trans), a construct containing the N-terminal apicoplast transit peptide, was NOT a substrate for pfMCAT, demonstrating that the transit peptide interferes with enzyme recognition.\",\n      \"method\": \"In vitro malonyl transfer assay with recombinant pfMCAT and pfACP; kinetic characterization of pfKASIII with malonyl-pfACP\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified recombinant proteins, kinetic parameters determined, negative control with transit-peptide-containing construct tested\",\n      \"pmids\": [\"12549938\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"P. falciparum ACP (apicoplast form) can functionally replace E. coli AcpP in vivo, restoring growth to an E. coli temperature-sensitive acpP mutant strain, demonstrating that PfACP is functionally interchangeable with bacterial ACP despite evolutionary distance.\",\n      \"method\": \"In vivo complementation of E. coli acpP temperature-sensitive mutant with recombinant PfACP\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean in vivo genetic complementation assay, single lab, single method\",\n      \"pmids\": [\"17522044\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"High-resolution NMR solution structures of holo-PfACP reveal two conformational equilibrium states arising from different orientations of the 4'-phosphopantetheine (4'-PP) prosthetic group; the 4'-PP interacts with the polypeptide backbone, and a conformational switch between the two states is proposed to be essential for ACP activation. The structures consist of three tightly packed helices stabilized by hydrophobic interactions.\",\n      \"method\": \"High-resolution NMR structure determination (20 structures each form, >1200 NOEs including 4'-PP-protein NOEs, backbone dihedral angles, hydrogen bonds)\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with functional validation of prosthetic group-protein interactions, multiple orthogonal NMR experiments in single rigorous study\",\n      \"pmids\": [\"16734426\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Falcilysin (FLN), a zinc metalloprotease found in the P. falciparum apicoplast, cleaves the transit peptide from apicoplast-resident ACP in vitro, supporting a role for FLN in transit peptide degradation after proteolytic release from ACP precursor protein.\",\n      \"method\": \"In vitro cleavage assay of ACP transit peptide by recombinant falcilysin; GFP-FLN transgenic parasite localization\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vitro cleavage assay is Tier 1 but ACP used only as substrate reagent; single lab, single biochemical assay for ACP-specific finding\",\n      \"pmids\": [\"17074076\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PfACP exhibits self-acylation activity intrinsic to the individual protein, selectively using dicarboxylic acids as substrates; mutational analysis identified key residues required for this self-acylation. This demonstrates that self-acylation is not restricted to ACPs in polyketide biosynthesis but extends to type II FAS ACPs.\",\n      \"method\": \"In vitro self-acylation assay with recombinant PfACP; site-directed mutagenesis of key residues\",\n      \"journal\": \"Chemistry & biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical assay combined with mutagenesis, single lab, two complementary methods\",\n      \"pmids\": [\"17656314\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NMR structural studies on acyl-ACP intermediates of P. falciparum show that the hydrophobic core of ACP can sequester acyl chains up to 12 carbons; additional carbons protrude from the hydrophobic cavity. A unique side chain-to-backbone hydrogen bond between Ile-55 HN and Glu-48 O, combined with charge-charge repulsion between helix II and helix III, provides the molecular mechanism for ACP core expansion to accommodate longer acyl chains.\",\n      \"method\": \"NMR (chemical shift perturbation, 13C,15N-double-filtered NOESY, pKa measurement) on acyl-ACP intermediates\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR with multiple orthogonal experiments (CSP, dNOESY, pKa), mechanistic conclusions validated by multiple NMR approaches in single rigorous study\",\n      \"pmids\": [\"19520851\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Recombinant PfACP from P. falciparum exhibits malonyl transferase activity intrinsic to the individual ACP; mutational analysis identifies an arginine/lysine in loop II and an arginine/glutamine in helix III as catalytic residues essential for the malonyl transferase reaction, and this activity can complement a fabD(Ts) E. coli strain.\",\n      \"method\": \"In vitro malonyl transferase assay; site-directed mutagenesis; in vivo complementation of fabD(Ts) E. coli\",\n      \"journal\": \"Molecular bioSystems\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic assay with mutagenesis plus in vivo genetic complementation, two orthogonal methods in single study\",\n      \"pmids\": [\"19462023\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The ACP targeting sequence is used to drive GFP to the apicoplast in live P. berghei parasites; live imaging shows the apicoplast remains as a single branched organelle until nuclear division is complete, then rapidly segregates into daughter cells across all three asexual replication phases.\",\n      \"method\": \"Live fluorescence microscopy of P. berghei expressing GFP fused to ACP targeting sequence; FRAP and time-lapse imaging\",\n      \"journal\": \"Biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct live-cell localization using ACP targeting sequence as apicoplast marker; ACP sequence used as tool, functional consequence of ACP localization itself not directly tested; single lab\",\n      \"pmids\": [\"19143588\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structures of P. falciparum ACP in both reduced (monomer) and disulfide-linked (dimer) forms reveal the disulfide in the cross-linked dimer is sequestered from bulk solvent at a tight molecular interface. Biochemical analysis of blood-stage parasites shows monomeric (reduced, holo) PfACP predominates; the disulfide-linked form is not detected even under oxidative stress, indicating the apicoplast maintains a reducing environment during blood-stage growth.\",\n      \"method\": \"X-ray crystallography of reduced and disulfide-linked ACP; solvent accessibility assays with reducing agents; non-reducing SDS-PAGE of parasite lysates; diamide treatment of blood-stage parasites\",\n      \"journal\": \"Proteins\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure plus multiple orthogonal biochemical experiments on parasite lysates in single rigorous study\",\n      \"pmids\": [\"19768685\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NMR analysis of the P. falciparum ACP transit peptide shows it is intrinsically disordered (unstructured) in vitro; in vivo mutagenesis studies demonstrate that increased helical content in the transit peptide disrupts apicoplast import, while transit peptides with proline-enforced disorder support robust apicoplast localization, establishing that structural disorder is a functional requirement for ACP transit peptide-mediated apicoplast targeting.\",\n      \"method\": \"NMR structural analysis of isolated transit peptide; in vivo apicoplast import assay with proline-substitution and helix-stabilizing mutants in P. falciparum\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR combined with functional in vivo import assay with multiple mutants, two orthogonal methods in single study\",\n      \"pmids\": [\"21668595\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"FabI (enoyl-ACP reductase) colocalizes with apicoplast-targeted ACP in P. falciparum oocyst sporozoites, confirming FabI functions in the apicoplast as part of the type II FAS pathway; targeted deletion of fabI and fabB/F abolishes sporozoite development within the midgut oocyst without affecting asexual blood-stage replication.\",\n      \"method\": \"Immunofluorescence colocalization of FabI with ACP; targeted gene deletion and phenotypic analysis across life cycle stages\",\n      \"journal\": \"Eukaryotic cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — colocalization used ACP as apicoplast marker; ACP itself not manipulated; finding is about FabI but validates ACP as apicoplast marker and FAS component\",\n      \"pmids\": [\"24297444\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ACP knockdown leads to loss of ACP immunofluorescence signal and loss of the apicoplast genome in P. falciparum PfΔGyrA parasites, indicating ACP is an established marker for apicoplast integrity used to confirm organelle loss.\",\n      \"method\": \"CRISPR/Cas9 gene editing of PfGyrA; ACP immunofluorescence as readout for apicoplast presence\",\n      \"journal\": \"Antimicrobial agents and chemotherapy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — ACP used only as immunofluorescence marker for apicoplast; no direct mechanistic study of ACP function\",\n      \"pmids\": [\"34152814\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A P. falciparum ACPS-type phosphopantetheinyl transferase (PfACPS-PPT) is responsible for synthesizing holo-ACP from apo-ACP; PfACPS-PPT is bifunctional (fused to a metal-dependent hydrolase domain), is predicted to be targeted to the apicoplast, and is more closely related to proteobacterial PPTases than to animal or SFP-type PPTases.\",\n      \"method\": \"Bioinformatic identification; functional characterization of homologous CpSFP-PPT by in vitro and in vivo assays in E. coli (PfACPS-PPT not directly assayed in vitro)\",\n      \"journal\": \"Eukaryotic cell\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — PfACPS-PPT identified bioinformatically; direct biochemical characterization performed only for C. parvum homolog, not PfACPS-PPT itself\",\n      \"pmids\": [\"16002647\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Knockout or ligand-dependent knockdown of apicoplast ACP (PF3D7_0208500) is lethal to blood-stage P. falciparum independently of type II fatty acid synthesis activity; loss of ACP impairs biosynthesis of essential isoprenoid precursors and blocks apicoplast biogenesis. Proximity biotinylation and biochemical interaction studies show ACP binds and stabilizes apicoplast pyruvate kinase II (PKII), the only known source of NTPs in the apicoplast; ACP knockdown causes loss of PKII, which is sufficient to explain ACP essentiality at this stage.\",\n      \"method\": \"CRISPR/Cas9 knockout; ligand-dependent knockdown (conditional expression); proximity biotinylation (BioID); co-immunoprecipitation/biochemical interaction studies; isoprenoid biosynthesis assay; apicoplast biogenesis imaging\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (genetic KO, conditional KD, proximity biotinylation, biochemical interaction, functional rescue assays) establishing a specific essential non-FAS mechanism\",\n      \"pmids\": [\"41959251\"],\n      \"is_preprint\": true,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"P. falciparum apicoplast ACP (PF3D7_0208500) is a nuclear-encoded protein bearing an N-terminal bipartite targeting sequence (signal peptide + intrinsically disordered transit peptide) that directs it to the apicoplast, where it is maintained in a reduced, holo (4'-phosphopantetheine-modified) state; it functions as the canonical acyl-chain scaffold and carrier for apicoplast type II fatty acid synthesis (accepting malonyl groups from MCAT, donating acyl intermediates to KASIII and other FAS enzymes, and expanding its hydrophobic core to accommodate growing acyl chains), and additionally exhibits intrinsic self-acylation and malonyl transferase activities; beyond FAS, ACP plays an essential FASII-independent role in blood-stage parasites by binding and stabilizing apicoplast pyruvate kinase II (PKII)—the sole NTP source in the organelle—thereby supporting isoprenoid precursor biosynthesis and apicoplast biogenesis, such that ACP loss is lethal in blood stages even when FAS is dispensable.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PF3D7_0208500 (ACP) is a nuclear-encoded apicoplast acyl carrier protein of P. falciparum that serves as the central acyl-chain scaffold of the organellar type II fatty acid synthesis (FASII) pathway [#0, #1]. It is imported into the apicoplast via an N-terminal bipartite presequence sufficient to target reporters to the organelle, whose transit peptide must remain intrinsically disordered for productive import and is proteolytically removed inside the apicoplast [#0, #11, #5]. ACP is activated to its holo form by addition of a 4'-phosphopantetheine prosthetic group derived from coenzyme A [#1], and its NMR/crystal structures reveal a three-helix fold whose hydrophobic core sequesters acyl chains up to twelve carbons and expands via defined helix II/III interactions to accommodate longer chains, with a conformational switch of the prosthetic group linked to activation [#4, #7]. In blood-stage parasites ACP is maintained predominantly in a reduced, monomeric holo state, reflecting a reducing apicoplast environment [#10]. Mechanistically, ACP accepts malonyl groups from MCAT to form malonyl-ACP and donates acyl intermediates to KASIII for decarboxylative condensation [#1, #2], and it additionally displays intrinsic self-acylation and malonyl transferase activities dependent on identified catalytic residues [#6, #8]; its functional interchangeability with bacterial ACP underscores the conservation of these roles [#3, #8]. Beyond FASII, ACP is essential in blood stages independently of fatty acid synthesis: it binds and stabilizes apicoplast pyruvate kinase II (PKII), and ACP loss depletes PKII, impairs isoprenoid precursor biosynthesis, and blocks apicoplast biogenesis, rendering ACP knockdown lethal [#15].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established where ACP acts and implicated apicoplast fatty acid biosynthesis as an essential organellar function, framing all subsequent mechanistic work.\",\n      \"evidence\": \"Immunolocalization of endogenous ACP in P. falciparum plus GFP presequence-targeting reporter in transgenic T. gondii\",\n      \"pmids\": [\"9770490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not test whether FASII/ACP is essential in blood stages\", \"No biochemical activity demonstrated\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrated that ACP requires 4'-phosphopantetheine activation to function as the acyl carrier that feeds KASIII, defining its core biochemical role in FASII.\",\n      \"evidence\": \"Recombinant expression, in vitro 4'-PP modification, and transacylase assay with PfKASIII\",\n      \"pmids\": [\"12270624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro reconstitution only\", \"Identity of the physiological PPTase not established here\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Placed ACP within the FASII enzyme cascade by showing it accepts malonyl from MCAT and that the transit peptide blocks enzyme recognition, indicating processing is required for function.\",\n      \"evidence\": \"In vitro malonyl transfer with recombinant pfMCAT and pfACP, kinetics with pfKASIII, and negative control with transit-peptide-containing construct\",\n      \"pmids\": [\"12549938\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Used recombinant proteins outside the organelle\", \"Did not resolve when/where the transit peptide is cleaved in vivo\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Tested the depth of functional conservation of ACP, showing the Plasmodium protein can substitute for bacterial ACP in vivo.\",\n      \"evidence\": \"In vivo complementation of an E. coli acpP temperature-sensitive mutant with PfACP\",\n      \"pmids\": [\"17522044\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-method genetic assay\", \"Does not address Plasmodium-specific partner interactions\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Proposed the enzyme responsible for generating holo-ACP, addressing how apo-ACP is activated in the apicoplast.\",\n      \"evidence\": \"Bioinformatic identification of PfACPS-PPT with functional characterization performed on the C. parvum homolog, not PfACPS-PPT itself\",\n      \"pmids\": [\"16002647\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"PfACPS-PPT never directly assayed on PfACP\", \"Apicoplast targeting only predicted\", \"No in vivo demonstration of holo-ACP synthesis by this enzyme\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Provided the atomic structure of holo-ACP and linked a prosthetic-group conformational switch to activation, explaining how the carrier presents its cargo.\",\n      \"evidence\": \"High-resolution NMR solution structures of two holo-PfACP conformers with 4'-PP-protein NOEs\",\n      \"pmids\": [\"16734426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of the two states not tested by mutation\", \"No acyl-loaded structure in this study\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Revealed an intrinsic self-acylation activity of ACP using dicarboxylic acids, expanding its catalytic repertoire beyond passive carrier function.\",\n      \"evidence\": \"In vitro self-acylation assay with recombinant PfACP plus site-directed mutagenesis of key residues\",\n      \"pmids\": [\"17656314\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of self-acylation in vivo unclear\", \"Single in vitro system\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined the structural basis for accommodating growing acyl chains, explaining how one carrier handles substrates of increasing length during FASII elongation.\",\n      \"evidence\": \"NMR of acyl-ACP intermediates (CSP, double-filtered NOESY, pKa) identifying core expansion mechanism\",\n      \"pmids\": [\"19520851\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Behavior with the full complement of FAS enzymes not tested\", \"Upper limit of chain capacity in vivo not established\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed ACP itself carries intrinsic malonyl transferase activity with identified catalytic residues, further blurring the carrier/enzyme boundary.\",\n      \"evidence\": \"In vitro malonyl transferase assay, mutagenesis, and in vivo complementation of a fabD(Ts) E. coli strain\",\n      \"pmids\": [\"19462023\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of this activity relative to MCAT in vivo unclear\", \"No parasite genetic test of the catalytic residues\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established that intrinsic disorder of the ACP transit peptide is a functional requirement for apicoplast import, defining the biophysical rule governing its targeting.\",\n      \"evidence\": \"NMR of the isolated transit peptide plus in vivo import assays with proline-disorder and helix-stabilizing mutants in P. falciparum\",\n      \"pmids\": [\"21668595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Import receptor recognizing the disordered peptide not identified\", \"Sequence-specific determinants not mapped\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Determined that ACP is kept in a reduced monomeric holo state in blood stages, establishing the redox environment of the functional carrier.\",\n      \"evidence\": \"X-ray crystallography of reduced and disulfide-linked forms plus non-reducing PAGE and diamide treatment of blood-stage parasites\",\n      \"pmids\": [\"19768685\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of the disulfide-linked dimer, if any, undefined\", \"Redox state in other life-cycle stages not examined\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Used ACP to define the FASII pathway's stage-specific requirement, showing FAS enzymes act in the apicoplast and are needed for mosquito-stage but not blood-stage growth.\",\n      \"evidence\": \"Immunofluorescence colocalization of FabI with ACP and targeted deletion of fabI and fabB/F across life-cycle stages in P. falciparum\",\n      \"pmids\": [\"24297444\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ACP itself not deleted here\", \"Does not address why ACP is essential in blood stages if FASII is dispensable\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Resolved the paradox of blood-stage essentiality by showing ACP acts independently of FASII, stabilizing PKII and supporting isoprenoid precursor synthesis and apicoplast biogenesis.\",\n      \"evidence\": \"CRISPR knockout, ligand-dependent knockdown, BioID proximity biotinylation, co-IP, isoprenoid and apicoplast biogenesis assays in P. falciparum (preprint)\",\n      \"pmids\": [\"41959251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of ACP-PKII binding not structurally defined\", \"Whether ACP stabilizes additional apicoplast proteins not established\", \"Preprint, not yet peer-reviewed\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ACP's canonical FASII carrier role is mechanistically coupled to its FASII-independent PKII-stabilizing function within the same molecule remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of the ACP-PKII complex\", \"Unknown whether the acyl-carrier and PKII-binding surfaces overlap\", \"Identity of the endogenous apicoplast PPTase remains bioinformatic\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0000036\", \"supporting_discovery_ids\": [1, 2, 7]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0031177\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0005515\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020011\", \"supporting_discovery_ids\": [0, 9, 10, 12, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0006633\", \"supporting_discovery_ids\": [1, 2, 12]},\n      {\"term_id\": \"GO:0008299\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"complexes\": [\n      \"ACP-PKII (apicoplast pyruvate kinase II) complex [#15]\"\n    ],\n    \"partners\": [\n      \"PfKASIII (beta-ketoacyl-ACP synthase III) [#1, #2]\",\n      \"PfMCAT (malonyl-CoA:ACP transacylase) [#2]\",\n      \"FabI (enoyl-ACP reductase) [#12]\",\n      \"Falcilysin (FLN, transit peptide cleavage) [#5]\",\n      \"PfACPS-PPT (predicted phosphopantetheinyl transferase) [#14]\",\n      \"Apicoplast pyruvate kinase II (PKII) [#15]\"\n    ],\n    \"other_free_text\": [\n      \"Nuclear-encoded, imported into the apicoplast via an N-terminal bipartite presequence; transit peptide must be intrinsically disordered for import [#0, #11].\",\n      \"Activated to holo form by 4'-phosphopantetheine addition; adopts a three-helix fold whose hydrophobic core expands to accommodate acyl chains up to and beyond 12 carbons [#4, #7].\",\n      \"Maintained predominantly reduced and monomeric in blood-stage parasites, reflecting a reducing apicoplast environment [#10].\",\n      \"Functionally interchangeable with bacterial ACP (E. coli acpP and fabD complementation) [#3, #8].\",\n      \"Essential in blood stages independently of type II fatty acid synthesis; loss blocks isoprenoid precursor biosynthesis and apicoplast biogenesis [#15].\",\n      \"Widely used as an apicoplast marker to monitor organelle integrity [#9, #13].\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_0208500","name":null,"product":"acyl carrier protein","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PbANKA","gene_id":"PBANKA_0305600","name":null,"product":"acyl carrier protein, putative","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"ACP","evaluation":null}